Pharmaceutical commercial stocks opened higher, with Yifeng Pharmacy hitting the daily limit, followed by DSL, Jointown, Hezong Medicine Easy-To-Buy Pharmaceutical, SYPM, and LBX. In terms of news, the Ministry of Commerce and 8 other departments issued the "Opinions on Promoting the High-Quality Development of the Pharmaceutical Retail Industry."Wallstreetcn·Jan 22 at 07:32 PM300937+2.21%301017+4.90%
A-share pharmaceutical commercial stocks continue to decline, with Shuyu Pingmin dropping over 18%. HRPC, DAJIAWEIKANG, INT'L GROUP, and Hezong Medicine Easy-To-Buy Pharmaceutical all fell more than 5%, while Huaren Health, CQP, and Kaikai Industry also followed suitWallstreetcn·Dec 28, 2025 at 11:13 PM000950+2.51%301126+4.38%
Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 742,100 yuan in the third quarter, a decrease of 140.42%Zhitong·Oct 23, 2025 at 06:49 AM300937+2.21%
The pharmaceutical commercial sector experiences a surge, China Meheco hits the daily limit upZhitong·Sep 18, 2025 at 12:15 AM600056+1.52%301017+4.90%
Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit loss of 7.6144 million yuan in the first half of 2025Zhitong·Aug 11, 2025 at 06:43 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical establishes a subsidiary, Shutan Artificial IntelligenceZhitong·Aug 5, 2025 at 06:49 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical and others invest to establish an artificial intelligence technology companyZhitong·Aug 4, 2025 at 11:44 PM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical and others establish a new technology company in SichuanZhitong·Jun 23, 2025 at 01:22 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical: Hainan Hesen and Chengdu Heqi plan to transfer 2.469 million shares, accounting for 2.58% of the total share capitalZhitong·May 22, 2025 at 06:21 AM300937+2.21%
Pharmaceutical commercial stocks opened strong, with YIXINTANG hitting the limit up, Hezong Medicine Easy-To-Buy Pharmaceutical rising over 10%, and JZJ, Saili Medical, Huaren Health, SYPM, and others following suitWallstreetcn·May 20, 2025 at 08:32 PM300937+2.21%605266+0.57%
Hezong Medicine Easy-To-Buy Pharmaceutical 2024 Annual ESG Report: Environmental investment of 70,900 yuan, water resource consumption decreased by at least 20% year-on-year36Kr·Apr 25, 2025 at 03:52 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical: Net profit of RMB 4.1837 million in the first quarter of 2025, a year-on-year decrease of 54.65%Zhitong·Apr 24, 2025 at 08:50 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 16.3582 million yuan, a decrease of 72.52%Zhitong·Apr 10, 2025 at 07:18 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical supervisor Tian Wenshu plans to reduce his holdings by no more than 1.25% of the sharesZhitong·Mar 18, 2025 at 06:41 AM300937+2.21%
Hezong Medicine Easy-To-Buy Pharmaceutical issued a profit warning, expecting an annual net profit of 14.5 million to 19.5 million yuan, a year-on-year decrease of 67.24% to 75.64%Zhitong·Jan 20, 2025 at 07:01 AM300937+2.21%
